LDHA and acute myeloid leukemia: In contrast to the Wang et al. study, where mouse HSCs, HPCs and AML cells were all shown to be equally impacted by complete loss of LDHA, we found that normal human HSPCs are less sensitive to LDHA inhibitors compared to AML blasts.